Women’s healthcare company TherapeuticsMD Inc (NASDAQ:TXMD) is one of the companies to have come on to the radars of many investors in recent days. Over the course of the past week, the TherapeuticsMD stock has managed to clock gains of as much as 7% and in this situation; it might be a good idea to take a look at an announcement from the company on October 15. On that day,…
The well known women’s healthcare company TherapeuticsMD (NASDAQ:TXMD) made a key announcement last week but that did not quite seem to impress investors and the stock tanked by as much as 9% last week. In this situation it might be a good idea for investors to perhaps figure out if the decline in the stock price could be an opportunity to get into the TherapeuticsMD stock. The company announce that…
TherapeuticsMD Inc. (NASDAQ:TXMD) stock is down 10% in a week. Recently the company reported its financial results forQ2 2021 ended June 30, 2021. The company reported net product revenue of ANNOCERA of $9.6 million, increasing $7.7 million from Q2 2020. There were around 7,200 ANNOVERA prescriptions reported during the quarter, a 202% YoY increase and a 17% QoQ increase. Most importantly, refill rates are still strong at 50% for qualifying…
